Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma

Recently, combination therapy with atezolizumab, a humanized monoclonal antiprogrammed death ligand-1 antibody, and bevacizumab, has become available for treatment of unresectable hepatocellular carcinoma (HCC). We herein report a 73-year-old man with advanced stage HCC who developed fatigue during...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsuyama, Yasuhito, Kageyama, Ken, Shinkawa, Hiroji, Yamamoto, Akira, Jogo, Atsushi, Sohgawa, Etsuji, Tanaka, Shogo, Takemura, Shigekazu, Kubo, Shoji, Ishizawa, Takeaki, Miki, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331133/
https://www.ncbi.nlm.nih.gov/pubmed/37434611
http://dx.doi.org/10.1016/j.radcr.2023.06.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331133/
https://www.ncbi.nlm.nih.gov/pubmed/37434611
http://dx.doi.org/10.1016/j.radcr.2023.06.012

Ejemplares similares